Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 717 | 262 | 1,001 | 792 | 374 |
| Depreciation Amortization | 197 | 105 | 450 | 350 | 254 |
| Income taxes - deferred | -210 | N/A | -224 | N/A | N/A |
| Accounts receivable | -554 | -163 | -320 | -487 | -243 |
| Accounts payable and accrued liabilities | 750 | 309 | -239 | -388 | -144 |
| Other Working Capital | -358 | 414 | 506 | -1,088 | -972 |
| Other Operating Activity | -189 | -146 | 545 | 875 | 387 |
| Operating Cash Flow | $353 | $781 | $1,719 | $54 | $-344 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -92 | -52 | -487 | -235 | -171 |
| Purchase Sale Intangibles | N/A | N/A | -146 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -146 | -63 | 0 |
| Investing Cash Flow | $-92 | $-52 | $-633 | $-298 | $-171 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38 | 38 | 26 | 22 | 2 |
| Financing Cash Flow | $38 | $38 | $26 | $22 | $2 |
| Beginning Cash Position | 2,708 | 2,708 | 1,596 | 1,596 | 1,596 |
| End Cash Position | 3,007 | 3,475 | 2,708 | 1,374 | 1,083 |
| Net Cash Flow | $299 | $767 | $1,112 | $-222 | $-513 |
| Free Cash Flow | |||||
| Operating Cash Flow | 353 | 781 | 1,719 | 54 | -344 |
| Capital Expenditure | -92 | -52 | -487 | -235 | -171 |
| Free Cash Flow | 261 | 729 | 1,232 | -181 | -515 |